Dyne Therapeutics, Inc.

DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818794

Price chart

Open-market purchases and sales by DYN insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 8, 20264:15 PM ETSep 4 – Sep 8, 2026Friedl-Naderer JohannaChief Commercial OfficerSSaleCommon Stock−1.09K$23.4173−$25.41K152.9K−0.7%SEC10b5-1
Sep 8, 20264:14 PM ETSep 4 – Sep 8, 2026Kerr DouglasChief Medical OfficerSSaleCommon Stock−5.04K$22.9486−$115.55K162.56K−3.0%SEC10b5-1
Sep 8, 20264:13 PM ETSep 8, 2026Cox JohnCEO & PresidentSSaleCommon Stock−5.66K$18.88−$106.82K357.51K−1.6%SEC10b5-1
Aug 17, 20265:30 PM ETAug 13 – Aug 14, 2026Rhodes Jason PDirectorSSaleCommon Stock−2.59M$25.1978−$65.18M428.95K−85.8%SEC10b5-1
Aug 17, 20264:08 PM ETAug 13, 2026Friedl-Naderer JohannaChief Commercial OfficerSSaleCommon Stock−226$26.28−$5.94K153.98K−0.1%SEC10b5-1

The largest institutional positions in DYN at the end of Q2 2026.

Institutions holding DYN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
T. Rowe Price Investment Management, Inc.30,912,287$686.56M0.45%+126,486+0.4%Added
BlackRock, Inc.12,404,330$275.5M0.00%+704,460+6.0%Added
Jupiter Topco LLC11,997,738$266.63M0.11%+11,997,738New
FMR LLC11,207,000$248.91M0.01%+2,298,020+25.8%Added
STATE STREET CORP7,458,263$165.65M0.00%+804,517+12.1%Added